Mechanism of Action.
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme essential for life, participating in over 500 enzymatic reactions. It exists in oxidized (NAD+) and reduced (NADH) forms, serving as an electron carrier in mitochondrial energy production through the electron transport chain. Beyond energy metabolism, NAD+ is a required substrate for three critical enzyme families: sirtuins (SIRT1-7), which regulate gene expression, DNA repair, and cellular stress responses; PARPs (poly-ADP-ribose polymerases), which mediate DNA damage repair; and CD38/CD157 ectoenzymes, which regulate calcium signaling and immune function. As a substrate (consumed, not recycled), NAD+ must be continuously replenished. Aging, DNA damage, and chronic inflammation dramatically increase NAD+ consumption through PARP and CD38 activation, creating a progressive deficit.
Research Summary.
Research has established that NAD+ decline is a hallmark of aging. Supplementation strategies include direct NAD+ administration and precursor supplementation (NMN, NR). In animal studies, NAD+ repletion has reversed age-related decline in muscle function, improved cognitive performance, enhanced DNA repair, restored mitochondrial function, and extended lifespan in some models. Human clinical trials with NMN and NR precursors have shown increases in blood NAD+ levels and improvements in various biomarkers. Direct NAD+ IV infusion is used clinically for addiction recovery and chronic fatigue, though controlled trial data is limited. Research is exploring NAD+ in neurodegeneration, cardiovascular disease, and metabolic syndrome.
Side Effects & Safety.
Direct NAD+ administration (IV or subcutaneous) can cause flushing, nausea, cramping, and localized discomfort during infusion. These effects are generally transient and dose-related. Oral precursors (NMN, NR) have demonstrated good tolerability in clinical trials at standard doses. Theoretical concerns include potential effects on cancer cell metabolism (cancer cells also depend on NAD+) and interactions with NAD+-consuming enzymes. Long-term safety data for supraphysiological NAD+ repletion is still being established. Individuals on medications metabolized by NAD+-dependent pathways should consult healthcare providers.
Legal Status & Access.
Direct NAD+ for injection is a research compound available from peptide suppliers. NAD+ precursors (NMN, NR) are widely available as dietary supplements. IV NAD+ infusion is offered by functional medicine and longevity clinics. NAD+ is not a controlled substance.